The company is supporting its professional pitch for the acne drug with a micro-targeted marketing strategy.
Business briefs: Abbott, IMS Health, Boehringer, plus healthcare reform
August 19, 2013
6:09 pm
Abbott’s Depakote lawsuits roll on; IMS buys mobile health firm’s assets; BI shutters a chemical plant; and the healthcare reform back-and-forth continues.
Business briefs: Eisai, Merck, plus another ACA delay
August 13, 2013
6:11 pm
Eisai lobbies to push back Belviq’s patent clock; a case against Paula Deen is dismissed; Merck and Avanir team up to promote Januvia; and another healthcare-reform measure is pushed back
Oncologists have the most restrictive access policies, a study shows for the second year in a row. But it’s not impossible to book face time with these clinicians.
Business briefs: J&J, Manhattan Research, plus July job cuts
August 1, 2013
5:13 pm
J&J sells off its feminine side; Manhattan Research’s study on the sales rep “tablet dance”; Cepheid rolls out a consumer TB campaign; and healthcare sector job losses top out in July.
Quarterly sales fell 11% compared to the same period last year. The company plans on weathering a continued flow of patent losses with a narrower R&D focus.